Navigation Links
Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
Date:8/30/2007

WASHINGTON, Aug. 30 /PRNewswire/ -- Prestwick Pharmaceuticals, Inc., a privately-held biotechnology company, today announced that it has hired Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer.

Dr. Stogniew will be responsible for Prestwick's pre-clinical development, regulatory and patent activities around its portfolio of products including its lead product candidate, tetrabenazine, a highly selective and reversible dopamine depletor in Phase 3 clinical trials for potential use as a treatment for chorea associated with Huntington's Disease.

He joins Prestwick most recently from Zelos Therapeutics, where he was Executive Vice President of Development responsible for pre-clinical, regulatory and patent development.

"With 25 years focused on developing drugs and 25 patents to his name, Marty will immediately help Prestwick as we work to execute and enhance our pipeline," said George F. Horner III, President and Chief Executive Officer of Prestwick. "He has made a significant impact in the development of successful drugs such as Anidulafugin, Amifostine and Idarubicin -- all of which are now on the market and positively impacting patients' lives."

Dr. Stogniew worked with Mr. Horner at Vicuron Pharmaceuticals, Inc. as Executive Vice President of Scientific Affairs from 2001 to 2005 before Vicuron was purchased by Pfizer in 2005 for $1.9 billion. Prior to Vicuron, Dr. Stogniew served as Chief Scientific Officer at Next Pharmaceuticals, Inc. and as Vice President of Pharmaceutical Sciences at MedImmune. Dr. Stogniew holds a Ph.D. in Medicinal Chemistry and a B.S. in Pharmacy from the University of Maryland.

About Prestwick

Prestwick is currently managing a portfolio of pipeline product candidates being studied for CNS conditions with significant unmet needs, including Huntington's disease, Parkinson's disease, restless legs syndrome, schizophrenia, autism, Alzheimer's disease and sleep apnea.

Pl
'/>"/>

SOURCE Prestwick Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Traveling stem cell show continues state tour
2. AT&T - BellSouth merger: Revestiture continues
3. Madison biotech continues its climb
4. Brady continues growth through Asian acquisition
5. Transition continues to impact Third Wave financials
6. Line between big pharma, big biotech continues to blur
7. Wisconsin giant continues to dominate the health care IT market
8. API Software continues expansion
9. Third Wave continues molecular diagnostic focus with new CEO
10. Midwest Public-Sector Biotech Continues to Sizzle
11. Corona Optical Systems continues to excite investors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...CHO CORDOVA, Calif., Nov. 5 /PRNewswire-FirstCall/...g supplier of innovative products for processing a...s for the first quarter of fiscal 2010. ,, For ...reported revenues of $5.2 million, a 15 percent in...quarter a year ago. The Company said the key contr...
(Date:11/5/2009)...T WORTH, Texas, Nov. 5 W...ced today that it has entered into a Letter of Int...irtual Health Technologies, Inc. (OTC Bulletin Boa...1,000,000 in cash and debt, 4,000,000 shares of WN...by WNDM on the Veriscrip technology being acquired...
(Date:11/5/2009)... Drug safety specialty firm BioSot...g and Informatics earned the Certified Professiona...tial from the American Society for Training and De...e Flewell has more than fifteen years of medical c...and is responsible for the development of the comp...
(Date:11/4/2009)...TSVILLE, Ala., Nov. 4 DIATHERIX La... ), today presented at the Michigan Security Netwo...in Dearborn, Mich. Dennis Grimaud, Chairman and Ch...impact of the company,s advanced molecular diagnos..., infectious disease diagnosis and military effort...
Breaking Biology Technology:ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4DIATHERIX Laboratories Presents at Homeland Security Conference 2
... Microtest has announced the,availability of a fre...l,Products: Partnering With a Contract Lab." In m... virus,contamination at many levels, from raw mate... virus testing is required. A proper testing,progr...chieves the fastest,time to market. By working wit...
... Campbell Alliance, the leading,management consult...otech,industries, today announced that the firm wa...the Research Triangle Park area of North Carolina ...ong midsize companies. The award,was presented to ... Best,Places to Work luncheon and awards ceremony ...
... Fourth Fo... Quarter Quarter Year Year ... 2007 2006 Net Sales by Segment Corn se...807 $1,793 Soybean seed and traits ... and traits 58 52 319 ...
Other Biology Technology:Microtest Offers Free White Paper: 'Virus Testing for Biological Products: Partnering With a Contract Lab' 2Campbell Alliance Named 'Best Place to Work' by Triangle Business Journal 2Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 2Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 3Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 4Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 5Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 6Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 7Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 8Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 9Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 10Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 11Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 12Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 13Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 14Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 15Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 16Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 17Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results 18
(Date:11/4/2009)...-- Global Rainmakers, Inc., an intellectual proper..., today announced that the company has exited its ...ialize its suite of technologies designed to lever..., During the past four years, the company has spe...oy a series of core--but expandable--technologies ...
(Date:11/4/2009)...swire/ -- GenVault Corporation (Carlsbad, CA) toda...oined its Board of Directors. Dr. Brody, the Irwi... is an acclaimed physician-scientist and universit.... Brody served as president of The Johns Hopkins U... of Engineering and the Institute of Medicine, and...
(Date:11/3/2009)...The world,s greatest wines are the result of a thr...nd something called the "terroir" -- a term often ... , Experts will discuss terroir with an emphasis... 4 in Pittsburgh. "Terroir: Winegrapes and the En...009 Annual Meetings of the American Society of Agr...
Breaking Biology News(10 mins):Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Great wines come from great soils 2Prepaid Emergency Travel Announces a Unique Service That Provides Peace of Mind During Family Emergencies 53181 1Prepaid Emergency Travel Announces a Unique Service That Provides Peace of Mind During Family Emergencies 53181 2Patrick Rummerfield Teams with Eric Westacott Foundation and Christopher and Dana Reeve Foundation to Help Young Quadriplegic Boy 53179 1Patrick Rummerfield Teams with Eric Westacott Foundation and Christopher and Dana Reeve Foundation to Help Young Quadriplegic Boy 53179 2Patrick Rummerfield Teams with Eric Westacott Foundation and Christopher and Dana Reeve Foundation to Help Young Quadriplegic Boy 53179 3Patrick Rummerfield Teams with Eric Westacott Foundation and Christopher and Dana Reeve Foundation to Help Young Quadriplegic Boy 53179 4Patrick Rummerfield Teams with Eric Westacott Foundation and Christopher and Dana Reeve Foundation to Help Young Quadriplegic Boy 53179 5ARDS Promotes Awareness with New Campaign 53177 1ARDS Promotes Awareness with New Campaign 53177 2
...omplicate treatment after many surgical procedures...cus aureus (MRSA), which has been found in many he... complication. In a study published in the April i...earchers found MRSA infections in the eyes of 12 p...first cases of MRSA infectious keratitis following...
...to weigh less than children who sleep less, and th...verweight five years later. That’s one of the majo.../February 2007 issue of the journal Child Developm...iversity, the study looked at 2,281 children from ...d Development Supplement of the Panel Survey of In...
... an eight-year, $22.5 million research program at ...nologies that produce biorenewable fuels. The gran...research programs with major universities to produ...sources. , ConocoPhillips will make an initial $1...earchers, with additional grants of $3 million per...
Other Biology News:Drug-resistant bacterial infections serious complication after corrective eye surgery 2Children who sleep more weigh less 2ConocoPhillips establishes $22.5M biofuels research program at Iowa State 2ConocoPhillips establishes $22.5M biofuels research program at Iowa State 3
...rogressive centrifuge design and manufacturing, Th... and Centra-CL3R (refrigerated) general purpose mo...y., Quality Control Over Sample Preparation ...otocols and has speed and accuracies to the neares...
...fluorescent and highly photostable FluoSpheres mic...iety of applications requiring probes that can del...other macromolecule-labeled microspheres have hydr...-target surfaces in some applications. This nonspe...
...se centrifuge offers both high-speed and high-vol...rotor options, making it ideal for a wide variety ...lity , High-speed (up to 15,000 rpm and 21,000 ...ng bucket rotors , Accommodates tube volumes fro...
...sed, high throughput, water bath thermal cycler ca...icroplates. This equates to 9,216 reactions per ru...idly transfers a basket of plates between three wa...hat are considerably faster than those of peltier ...
Biology Products: